Thierry M. Muanza

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Uterine Transposition Prior to Pelvic Radiation: First Canadian Center.

Uterine Transposition Prior to Pelvic Radiation: First Canadian Center.

Journal: International journal of radiation oncology, biology, physics

Published: September 06, 2025

Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study.

Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study.

Journal: International journal of radiation oncology, biology, physics

Published: July 18, 2025

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Journal: Neuro-oncology practice

Published: July 03, 2025

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

Journal: The New England journal of medicine

Published: June 04, 2025

Models and Biomarkers for Local Response Prediction in Early-Stage and Oligometastatic Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Using Machine Learning.

Models and Biomarkers for Local Response Prediction in Early-Stage and Oligometastatic Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Using Machine Learning.

Journal: Cureus

Published: December 16, 2024

Radiomics As Biomarkers for the Treatment of Non-small Cell Lung Cancer With Stereotactic Body Radiation Therapy: A Review of Concepts.

Radiomics As Biomarkers for the Treatment of Non-small Cell Lung Cancer With Stereotactic Body Radiation Therapy: A Review of Concepts.

Journal: Cureus

Published: November 03, 2024

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

Journal: Frontiers in oncology

Published: March 29, 2023

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 10, 2023

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 19, 2022

Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult.

Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: February 02, 2022

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

Journal: Lancet (London, England)

Published: December 21, 2021

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Journal: OncoTargets and therapy

Published: November 02, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026